Quantum-Si incorporated (QSI)
NASDAQ: QSI · IEX Real-Time Price · USD
1.670
-0.030 (-1.76%)
At close: Apr 24, 2024, 4:00 PM
1.710
+0.040 (2.40%)
After-hours: Apr 24, 2024, 7:44 PM EDT
Company Description
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.
The company was founded in 2013 is headquartered in Branford, Connecticut.
Quantum-Si incorporated
| Country | United States |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 159 |
| CEO | Jeffrey Alan Hawkins |
Contact Details
Address: 29 Business Park Drive Branford, Connecticut 06405 United States | |
| Phone | (203) 458-7100 |
| Website | quantum-si.com |
Stock Details
| Ticker Symbol | QSI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001816431 |
| CUSIP Number | 74765K105 |
| ISIN Number | US74765K1051 |
| Employer ID | 85-1388175 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jonathan M. Rothberg Ph.D. | Founder and Executive Chairman |
| Jeffrey Alan Hawkins | President, Chief Executive Officer and Director |
| Jeffry R. Keyes | Chief Financial Officer and Treasurer |
| Dr. Grace Johnston Ph.D. | Chief Commercial Officer |
| Todd Rearick | Chief Technology Officer |
| Juan Esteban Avendano | Vice President of Investor Relations |
| Dr. Christian Lapointe J.D., Ph.D. | General Counsel and Corporate Secretary |
| Alex A. Hutcheson | Senior Vice President of Sales and Service |
| Katherine Atkinson | Senior Vice President of Demand Generation and Corporate Brand |
| Johan Denecke | Senior Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 9, 2024 | 8-K | Current Report |
| Apr 1, 2024 | ARS | Filing |
| Apr 1, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 1, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 22, 2024 | PRE 14A | Other preliminary proxy statements |
| Mar 21, 2024 | 8-K | Current Report |
| Mar 11, 2024 | 8-K | Current Report |
| Feb 29, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 29, 2024 | 10-K | Annual Report |
| Feb 29, 2024 | 8-K | Current Report |